Vimarsana
Biggest News Aggregation in the World

Page 2 - Valtech Cardio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Valtech Cardio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Valtech Cardio Today - Breaking & Trending Today

PEREGRINE VENTURES ANNOUNCES USD 300 MILLION EXIT FROM TRANSCATHETER MITRAL AND TRICUSPID VALVE REPLACEMENT COMPANY, CARDIOVALVE, BRINGING TOTAL PROCEEDS TO USD 1 BILLION - Vimarsana News

PEREGRINE VENTURES ANNOUNCES USD 300 MILLION EXIT FROM TRANSCATHETER MITRAL AND TRICUSPID VALVE REPLACEMENT COMPANY, CARDIOVALVE, BRINGING TOTAL PROCEEDS TO USD 1 BILLION

Published: January 18, 2022

/PRNewswire/ -- Peregrine Ventures, a leading investment firm dedicated to supporting life changing healthcare opportunities, today announced its USD 300...

Source: prnewswire.com
Related Topics:
United StatesAmir GrossEyal LifschitzEdwards LifesciencesCardiovalve LtdPeregrine VenturesValtech CardioGeneral PartnerCo Founder Eyal LifschitzBoard MemberIncentive IncubatorCardiovalve SystemBanking Amp Financial ServicesHealth Care Amp Hospitals Venture Capital
PEREGRINE VENTURES ANNOUNCES USD 300 MILLION EXIT FROM TRANSCATHETER MITRAL AND TRICUSPID VALVE REPLACEMENT COMPANY, CARDIOVALVE, BRINGING TOTAL PROCEEDS TO USD 1 BILLION - Vimarsana News

PEREGRINE VENTURES ANNOUNCES USD 300 MILLION EXIT FROM TRANSCATHETER MITRAL AND TRICUSPID VALVE REPLACEMENT COMPANY, CARDIOVALVE, BRINGING TOTAL PROCEEDS TO USD 1 BILLION

Published: January 18, 2022

/PRNewswire/ -- Peregrine Ventures, a leading investment firm dedicated to supporting life changing healthcare opportunities, today announced its USD 300...

Source: prnewswire.com
Related Topics:
United StatesAmir GrossEyal LifschitzEdwards LifesciencesCardiovalve LtdPeregrine VenturesValtech CardioGeneral PartnerCo Founder Eyal LifschitzBoard MemberIncentive IncubatorCardiovalve SystemBanking Amp Financial ServicesHealth Care Amp Hospitals Venture Capital
Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement - Vimarsana News

Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement

Published: December 9, 2021

/CNW/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its...

Source: newswire.ca
Related Topics:
Hong KongNordrhein WestfalenAmir GrossEric ZiJill LiuEdwards LifesciencesFrancesco MaisanoVenus MedtechValve CenterSan Raffaele University HospitalVenus Medtech Hangzhou IncCardiovalve LtdPiedmont Heart InstituteMitraltech LtdValgen Holding CorporationEuropean Society Of CardiologyUniversity Heart CenterCenter University Clinic BonnValtech CardioCardiovalve SystemSan DonatoUniversitaet MainzHeart Center University Clinic BonnMedical ClinicBreakthrough Device Designation
Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement - Vimarsana News

Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement

Published: December 8, 2021

/PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its...

Source: prnewswire.com
Related Topics:
Hong KongNordrhein WestfalenAmir GrossEric ZiEdwards LifesciencesFrancesco MaisanoVenus MedtechValve CenterSan Raffaele University HospitalVenus Medtech Hangzhou IncCardiovalve LtdPiedmont Heart InstitutePrnewswire Venus Medtech Hangzhou IncMitraltech LtdValgen Holding CorporationEuropean Society Of CardiologyUniversity Heart CenterCenter University Clinic BonnValtech CardioCardiovalve SystemSan DonatoUniversitaet MainzHeart Center University Clinic BonnMedical ClinicBreakthrough Device Designation
Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement - Vimarsana News

Venus Medtech Acquires Cardiovalve to Optimize its Innovative Products Pipeline of Mitral and Tricuspid Valve Replacement

Published: December 8, 2021

/PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its...

Source: prnewswire.com
Related Topics:
Hong KongNordrhein WestfalenAmir GrossEric ZiEdwards LifesciencesFrancesco MaisanoVenus MedtechValve CenterSan Raffaele University HospitalVenus Medtech Hangzhou IncCardiovalve LtdPiedmont Heart InstitutePrnewswire Venus Medtech Hangzhou IncMitraltech LtdValgen Holding CorporationEuropean Society Of CardiologyUniversity Heart CenterCenter University Clinic BonnValtech CardioCardiovalve SystemSan DonatoUniversitaet MainzHeart Center University Clinic BonnMedical ClinicBreakthrough Device Designation